We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAB:ASXNational Australia Bank Limited Analysis

Data as of 2026-08-28 - not real-time

A$38.29

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind National Australia Bank Limited is neutral at AUD 38.29, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 3.9%. RSI sits at 37.3, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at AUD 37.70 up to resistance at AUD 43.08.
The shares look fair, trading on 19.1 times earnings above a sector average of 17.0. Revenue is growing at 6.1% on a 29.3% profit margin. The 4.44% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 21.7%, a beta of 0.33 and a maximum drawdown of 27.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Australian shares fell on Monday as firms missed earnings expectations and softer economic data loweA leading expert forecasts growing headwinds for NAB shares.Materials, banking, healthcare and retail heavyweights reveal diverging outlooks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 41.34
  • MACD momentum is negative
  • Maximum drawdown of 27.3%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 19.1 versus sector average of 17.0
  • Trading below the 200-day average of 41.34
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 19.1 versus sector average of 17.0
  • Profit margin of 29.3% is healthy
  • Dividend yield of 4.44%

Key Metrics & Analysis

Financial Health

Revenue Growth6.10%
Profit Margin29.26%
P/E Ratio19.1
P/B Ratio1.9
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI37.3
SupportA$37.70
ResistanceA$43.08
MA 20A$40.15
MA 50A$39.65
MA 200A$41.34
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Target PriceA$38.38
Upside/Downside0.24%
GradeFair
TypeBlend
Dividend Yield4.44%

Risk Assessment

Beta0.33
Volatility21.68%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.